Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants
Go back to Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants| (NASDAQ: MDGL) | Delayed: 465.42 -2.12 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $467.54 | 52 Week High | $18.24 | |||
| Open | $467.90 | 52 Week Low | $6.60 | |||
| Day High | $481.87 | P/E | N/A | |||
| Day Low | $462.12 | EPS | $0.00 | |||
| Volume | 197,431 | |||||



